[HTML][HTML] Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence
Abstract While Trade-Related Aspects of Intellectual Property Rights (TRIPS) was expected
to hike up prices of patented medicines, there was no consensus on its likely final impact on …
to hike up prices of patented medicines, there was no consensus on its likely final impact on …
Breaking Bad Patents: Learning from HIV/AIDS to make COVID-19 treatments accessible
The COVID-19 pandemic has brought renewed attention to the topic of challenging drug
patents in the interest of public health. Pharmaceutical companies have already begun to …
patents in the interest of public health. Pharmaceutical companies have already begun to …
Improving access to HIV/AIDS treatment in Brazil: when are compulsory licenses effective in price negotiations?
EMP Urias - 2015 - cris.maastrichtuniversity.nl
Since 1996, Brazil has an anti-AIDS programme that offers universal and free access to
antiretroviral through the public-sector health system. An important part of the successful …
antiretroviral through the public-sector health system. An important part of the successful …
[HTML][HTML] Canada and access to medicines in developing countries: intellectual property rights first
J Lexchin - Globalization and health, 2013 - Springer
Canadian reports have recommended that health as a human right must be Canada's
overarching global commitment and that the primacy of human rights should be prioritized …
overarching global commitment and that the primacy of human rights should be prioritized …
El impacto del sistema de patentes farmaceúticas y el derecho fundamental a la salud: La aplicación de las licencias obligatorias en el contexto generado por la …
MA San Roman Gonzales - 2022 - repositorio.ucsp.edu.pe
La actual crisis sanitaria originada por la pandemia de la COVID-19, enfermedad infecciosa
causada por el SARS-CoV-2, ha puesto sobre la mesa el ya abierto debate sobre los …
causada por el SARS-CoV-2, ha puesto sobre la mesa el ya abierto debate sobre los …